FluoSphera

FluoSphera is a finalist in the RESI Boston Innovator's Pitch Challenge (IPC)! 🎉 CEO Clélia Bourgoint will showcase their groundbreaking work on Wednesday, September 25, at the Westin Copley Place. The IPC is an opportunity for founders and CEOs to standout during RESI. Each session features a Q&A with active hashtag #earlystage hashtag #investor judges, providing invaluable feedback and exposure. 🚀 Don't miss your chance to participate! Applications for RESI Boston are open through Wednesday, August 14. Secure your spot now: https://lnkd.in/exvmSKqv #RESI #RESIBOS #RESIBOSTON #LifeScience #Healthcare #Innovation

JUST PUBLISHED! Read more about "Unlocking the Potential of Antibody-Drug Conjugates in Cancer Therapy" in our recent article. Connect with us to learn more about how FluoSphera is revolutionizing ADC development and transforming cancer treatment.

🌟 It's Time to Vote! 🌟 Make your voice heard by voting for FluoSphera! Click the link below and select "Vote Now" at the top of the page: 🔗 https://lnkd.in/eQxTTG-5 Each vote is crucial to help us join the prestigious #Top100 Swiss Startups ranking! ⏳ Voting closes on July 21, so don’t wait – cast your vote today and be part of our journey to the top! FONGIT Science Innovation Hub - UNIGE University of Geneva SOSV IndieBio Venturelab EFI Lake Geneva Ventures Mountain Labs iGEM Startups C14 Consulting Group, LLC Faculty of Science | University of Geneva Unitec Technology Transfer Office Libérez vos idées – UNIGE bench2biz

FluoSphera is the only company with a suite of systemic & high-throughput in vitro drug discovery solutions. Want to learn more? Connect with Co-founders Clélia Bourgoint & Gregory Segala.

This week, we attended RESI EUROPE 2024 in Barcelona. This event was a fantastic opportunity for networking with investors and strategic partners. The conference featured expert speakers ranging from entrepreneurs presenting their companies or sharing their journeys to investors discussing their funds and perspectives on the current fundraising landscape. It was particularly rewarding to connect and exchange ideas with fellow European entrepreneurs! Looking forward to the next steps and the collaborations that will emerge from this event! #Networking #Entrepreneurship #Innovation #Fundraising #RESIEUROPE2024

This week, we attended RESI EUROPE 2024 in Barcelona. This event was a fantastic opportunity for networking with investors and strategic partners. The conference featured expert speakers ranging from entrepreneurs presenting their companies or sharing their journeys to investors discussing their funds and perspectives on the current fundraising landscape. It was particularly rewarding to connect and exchange ideas with fellow European entrepreneurs! Looking forward to the next steps and the collaborations that will emerge from this event! #Networking #Entrepreneurship #Innovation #Fundraising #RESIEUROPE2024

Last week, FluoSphera was at the MPS World Summit at the Seattle Convention Center Summit Building. This year's conference was particularly special as we were invited to speak in the session "MPS for Drug Discovery: From Target Identification to Candidate Selection." We presented our proprietary chip-free platform that uses flexible 3D cell systems to mimic the complex biology of the human body, enabling rapid and precise studies of human response to systemic drug delivery. The MPS World Summit showcased insightful keynotes, cutting-edge research presentations, and truly inspiring discussions, making it a pivotal event for following innovation and fostering new collaborations in the field. Lastly, we express our gratitude to the organizers whose hard work made this event a success! We’re excited about the connections we made and look forward to building new collaborations!

Read what COO, Clélia Bourgoint, has to say about FluoSphera's collaboration with Revvity.

👏👏👏

I'm speaking today at MPS World Summit! Please join Gregory Segala from 1:00 - 1:20 pm on June 12 for "MPS for drug discovery, from target identification to candidate selection." See the full program here >> https://lnkd.in/eZXNeZva